How are you using the data on cardiac morbidity in regards to the LV-V5 in breast cancer patients?   

Is there a dose constraint you are using for LV-V5?

https://www.ncbi.nlm.nih.gov/pubmed/28095159?dopt=Abstract



Answer from: Radiation Oncologist at Community Practice